Development Level

Tchem 5 | 1,890
Tclin 2 | 602
Tbio 1 | 10,625

IMPC Term

decreased circulating creatini... 1 | 31
increased circulating creatini... 1 | 29
increased circulating sodium l... 1 | 71
increased mean corpuscular vol... 1 | 91

Disease

Cancer 7 | 2,346
Liver disease 6 | 219
diabetes mellitus 5 | 1,663
Drug-Induced Liver Injury 4 | 118
osteosarcoma 4 | 7,933
Acute kidney injury 3 | 65
Adverse reaction to drug 3 | 54
Cholestasis 3 | 93
Epilepsy 3 | 346
Hepatomegaly 3 | 10
Schizophrenia 3 | 501
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,289
medulloblastoma, large-cell 3 | 6,234
pancreatic cancer 3 | 2,300
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,795
psoriasis 3 | 6,685
Atrial Fibrillation 2 | 110
Autoimmune hepatitis 2 | 13
Bilirubin metabolic disorder 2 | 39
Coronary artery disease 2 | 240
Hepatitis C 2 | 90
Leber congenital amaurosis 2 | 72
Liver Neoplasms, Experimental 2 | 48
Major Depressive Disorder 2 | 106
Mammary Neoplasms 2 | 410
Metabolic syndrome X 2 | 155
Neonatal jaundice 2 | 15
Nephritis, Interstitial 2 | 10
Obesity 2 | 616
Pain agnosia 2 | 99
Prostatic Neoplasms 2 | 471
astrocytic glioma 2 | 2,241
ependymoma 2 | 2,514
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
ovarian cancer 2 | 8,484
tuberculosis 2 | 1,557
Adenocarcinoma 1 | 115
Androgen insensitivity syndrome 1 | 11
Aspergillosis 1 | 23
Atrophic 1 | 10
Barrett Esophagus 1 | 16
Bradycardia 1 | 24
Brain Neoplasms 1 | 23
Cardiomyopathies 1 | 90
Cardiovascular system disease 1 | 194
Cardioversion of Atrial Fibrillation 1 | 9
Cerebrotendinous xanthomatosis 1 | 12
Chronic Obstructive Airway Disease 1 | 47
Chronic cystitis 1 | 3
Colorectal Neoplasms 1 | 217
Constipation 1 | 43
Delusional disorder 1 | 10
Dementia 1 | 129
Diarrhea 1 | 155
Drug allergy 1 | 36
Dystonia 1 | 77
Esophageal Neoplasms 1 | 67
Esophageal candidiasis 1 | 3
Esophagitis 1 | 26
Exanthem 1 | 39
Fatty Liver 1 | 48
Fatty liver disease 1 | 84
Female infertility 1 | 28
Gastritis 1 | 44
Gastroesophageal reflux disease 1 | 37
Growth Disorders 1 | 33
Hemorrhage 1 | 18
Hepatitis D 1 | 10
Hepatocellular Adenoma 1 | 10
Human immunodeficiency virus infectious disease 1 | 92
Hypophosphatemia 1 | 31
Kidney Failure, Chronic 1 | 45
Life-Threatening Ventricular Tachycardia 1 | 15
Liver Cirrhosis, Experimental 1 | 108
Liver diseases 1 | 66
Liver neoplasms 1 | 109
Lung Injury 1 | 20
Lung Neoplasms 1 | 171
Malignant iris melanoma 1 | 1
Metastatic Prostate Carcinoma 1 | 18
Methemoglobinemia 1 | 17
Motion sickness 1 | 32
Muscle Rigidity 1 | 5
Neural Tube Defects 1 | 27
Neutropenia 1 | 78
Occupational Diseases 1 | 8
Parkinson Disease 1 | 102
Polycystic kidney disease 1 | 54
Precancerous Conditions 1 | 69
Prenatal Exposure Delayed Effects 1 | 9
Prevention of Motion Sickness 1 | 3
Pseudobulbar affect 1 | 5
Sclerosing cholangitis 1 | 16
Squamous cell carcinoma 1 | 94
Tonic-clonic epilepsy 1 | 47
Toxic encephalopathy 1 | 131
Vertigo 1 | 3
Weight Gain 1 | 87
nervous system disorder 1 | 53
obsessive-compulsive disorder 1 | 34

Tissue

Blood and immune system 8 | 17,995
Cardiovascular System 8 | 17,958
Digestive Tract 8 | 18,473
Endocrine System 8 | 18,512
Female tissues 8 | 18,647
Liver and Pancreas 8 | 18,136
Male tissues 8 | 17,969
Nervous System 8 | 18,561
Respiratory system 8 | 17,484
Skin and soft tissues 8 | 18,115
Urinary Tract 8 | 18,444

Target Family

Enzyme 3 | 4,146
Non-IDG 3 | 11,971
Nuclear Receptor 2 | 48

Grant Application

1R21AT002907-01A1 8 | 8
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Nuclear receptor subfamily 1 group I member 3 NR1I3 Tchem Nuclear Receptor -2.51708 258.1 278
Glycerol-3-phosphate phosphatase PGP Tbio Enzyme -1.98314 94.7 69
Cytochrome P450 2C19 CYP2C19 Tchem Non-IDG -3.17457 1627.4 145
Nuclear receptor subfamily 1 group I member 2 NR1I2 Tchem Nuclear Receptor -3.10727 1473.5 263
Cytochrome P450 2D6 CYP2D6 Tclin Enzyme -3.50005 3352.9 382
Cytochrome P450 2C9 CYP2C9 Tchem Non-IDG -3.17625 1560.3 155
Cytochrome P450 3A4 CYP3A4 Tclin Enzyme -3.62253 4494.0 323
Cytochrome P450 1A2 CYP1A2 Tchem Non-IDG -3.30248 2022.5 420